Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Supports Research Use Of Cellvizio On COVID-19 Patients

March 17 (Reuters) - MAUNA KEA TECHNOLOGIES SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES SUPPORTS CLINICAL RESEARCH
EVALUATING USE
OF CELLVIZIO ON COVID-19 PATIENTS WITH RESPIRATORY INSUFFICIENCY
    * CO IS OFFERING IN-KIND FUNDING TO RESEARCHERS EVALUATING
WHAT
ROLE CELLVIZIO MAY PLAY IN CARE MANAGEMENT OF COVID-19 PATIENTS

Source text for Eikon:  ID:nBw2tMw7Ga 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Mauna Kea Technologies SA

See all news